Single award · contract
COVID-19 Antigen OTC Test Kits
Award ID: W58P0522C0008
FY2022 · complete year · data as of 2026-07-11
A single federal award, with both ends of the trail linked.
$1.3B
Total award value
Award W58P0522C0008 is a contract from the Department of Defense to Abbott Rapid DX North America LLC, $1.3B obligated, FY2022, for COVID-19 Antigen OTC Test Kits. The work is performed in Florida. It is classified as NAICS 325413 (In-Vitro Diagnostic Substance Manufacturing) and PSC 6515 (Medical and Surgical Instruments, Equipment, and Supplies). Source
Award details
Award typeContract
PIIDW58P0522C0008
Action date2022
Period5 mo
Awarding agencyDepartment of Defense →
RecipientAbbott Rapid DX North America LLC →
Place of performanceFlorida →
CategoryNAICS 325413PSC 6515
Competed?Not recordedSource
Total (exact)$1,348,550,000
More awards to Abbott Rapid DX North America LLC
awarded 2021$357M
awarded 2021$265.7M
awarded 2021$264M
awarded 2022$257.1M
awarded 2020$174.4M
More from Department of Defense
awarded 2016$51.3B
awarded 2017$35.7B
awarded 2017$35.1B
awarded 2001$34.2B
awarded 2011$32B
Why the labels? The graph is only worth anything if the links are trusted. Facts taken straight from a federal filing are Source; figures we calculate are Computed; links we infer (corporate parents, districts, similar contractors, connections between records) are Inferred, worded carefully, never asserted as fact and never a claim that one thing caused another. Spot an error? Tell us.